BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Melanoma Institute Australia
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260218
DTEND;VALUE=DATE:20260222
DTSTAMP:20260428T050047
CREATED:20251201T051717Z
LAST-MODIFIED:20251201T053438Z
UID:10000216-1771372800-1771718399@melanoma.org.au
SUMMARY:AACR Immuno-Oncology Conference (AACR IO)
DESCRIPTION:Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through Immunotherapy \nThe AACR Immuno-Oncology Conference (AACR IO) is being held in Los Angeles from 18 to 23 February 2026. \nAACR IO encompasses the very best of basic\, translational\, and clinical research in immunology\, inflammation\, and immunotherapies for cancer\, including immuno-oncology (IO) drugs\, inflammatory modulators\, vaccines\, and cellular therapies. \nThe inaugural AACR IO program in 2026 attracted over 600 scientists\, translational researchers\, clinical investigators\, regulators\, industry\, investors\, and lay press. \nThe unique format will include a mix of keynote lectures\, major symposia\, spotlight sessions\, educational sessions\, special sessions\, and poster sessions with exhibits. \nLocation: JW Marriott Los Angeles L.A. LIVE\, 900 W Olympic Blvd\, Los Angeles\, CA 90015\, United States \nKey Dates: \nAdvance Registration Deadline: Friday 9 January 2026. \nClinical Trial and Late-Breaking Abstract Submission Deadline: Tuesday 20 January 2026\, 1 p.m. ET (opens Monday 5 January 2026) \nFIND OUT MORE
URL:https://melanoma.org.au/event/2026-aacr-immuno-oncology-conference/
LOCATION:JW Marriott Los Angeles\, 900 W Olympic Boulevard\, Los Angeles\, CA\, 90015\, United States
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/png:https://melanoma.org.au/wp-content/uploads/2025/12/AACR-IO-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260225
DTEND;VALUE=DATE:20260228
DTSTAMP:20260428T050047
CREATED:20260107T091047Z
LAST-MODIFIED:20260107T215349Z
UID:10000233-1771977600-1772236799@melanoma.org.au
SUMMARY:Melanoma Research Alliance 2026 Retreat
DESCRIPTION:MRA’s Annual Scientific Retreat is the premier annual convening of global thought leaders from across the melanoma research community. By bringing together physician scientists\, pharmaceutical and biotech representatives\, government officials\, and patient advocates\, this invitation-only\, think-tank style conference aligns key stakeholders to present and discuss emerging ideas and issues shaping melanoma research from bench to bedside. \nThe 2026 MRA Scientific Retreat will continue MRA’s history of featuring scientific excellence\, facilitating interaction and early sharing of unpublished data through lectures including keynotes\, panel discussions\, networking roundtables\, and virtual poster presentations. Participants will include leading scientists from the United States and abroad\, as well as senior leadership from non-profit foundations\, government agencies\, industry\, philanthropists\, and other like-minded organizations. \n2026 Scientific Retreat Highlights:\n• Three day\, invitation-only event attended by premier melanoma researchers worldwide\n• 300+ global leaders in melanoma; over 60% are academic researchers\n• 20+ presentations from world-leading melanoma researchers sharing largely unpublished data\n• Small group\, topic-focused networking opportunities\n• Poster presentations from MRA-funded investigators\, including opportunities for live Q&A\n• Topics include cutting-edge research results in prevention\, detection\, and treatment development \nLocation: Hyatt Regency Washington on Capitol Hill\, Washington\, D.C.\, United States \nDates: February 25-27\, 2026 \nPlease Note: The retreat is an invitation-only event. \nFIND OUT MORE
URL:https://melanoma.org.au/event/mra-retreat-2026/
LOCATION:Hyatt Regency Washington on Capitol Hill\, Washington\, D.C.\, United States
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/01/Melanoma-Research-Alliance-1.jpg
END:VEVENT
END:VCALENDAR